View Press Releases
-
Northeast Georgia Health System Elevates Its Digital Consumer Experience with Self-Service Capabilities from Kyruus
-
VERICHEM LABORATORIES ANNOUNCES EXTENDED STABILITY CLAIMS FOR ITS AMMONIA/IRON CLINICAL REFERENCE STANDARD
VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.
Mar 7, 2021
-
Standigm Secures $44.5 M in Pre-IPO Funding Round
Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.
Mar 4, 2021
-
Evolving Risks, Insecure Defaults, Watering Hole Threats: New Research from Accurics Uncovers Developing Sources of Cloud Risk
-
Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation
A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.
Feb 17, 2021
-
Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth
-
Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO
-
Ashfield Healthcare Communications rebrands as Ashfield Health, launches two new global agencies and appoints former McCann Health Americas head as Global President.
• Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network. • Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency. • Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse. • Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’
Jan 25, 2021
-
Europital board forewarns that clinical deficits to slow biotech development in 2021
-
Ashfield Engage launches with an integrated offering to maximize engagement with patients, HCPs and payers
-
John Snow Labs Announces Inaugural Healthcare NLP Summit in Response to Industry Demand
John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
Feb 1, 2021
-
SeqOnce Biosciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant
SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Feb 14, 2021
-
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
-
CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients
CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.
Feb 15, 2021
-
NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-pyrimidine inhibitors of malaria parasite Plasmodium falciparum dihydrofolate reductase (PfDHFR).
In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.
Feb 15, 2021
-
ComputaBio is Capable to provide Drug Design Services
ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.
Feb 23, 2021
-
VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine
-
IntelyCare Hires David Burke as CFO to Drive Business Growth and Momentum; Address Intensifying Staffing Demands in Post-Acute Space
IntelyCare hires David Burke as chief financial officer to support the continued success and expansion of the company.
Feb 23, 2021
-
Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service
-
Creative Biostructure Performs Comprehensive Lead Discovery and Optimization Solutions